We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$15.1B
AUM Growth
+$2.22B
Cap. Flow
+$548M
Cap. Flow %
3.64%
Top 10 Hldgs %
28.62%
Holding
2,384
New
671
Increased
477
Reduced
577
Closed
562

Sector Composition

Rank Sector Weight
1 Industrials 11.79%
2 Technology 9.94%
3 Financials 9.21%
4 Consumer Discretionary 9.02%
5 Healthcare 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
201
Nasdaq
NDAQ
$52.6B
$16.7M 0.11%
287,879
-159,031
-36% -$8.38M
CROX icon
202
Crocs
CROX
$6.47B
$16.6M 0.11%
177,737
+59,528
+50% +$5.5M
MDB icon
203
MongoDB
MDB
$28.8B
$16.6M 0.11%
40,500
+10,515
+35% +$3.99M
BMRN icon
204
BioMarin Pharmaceuticals
BMRN
$11.6B
$16.5M 0.11%
171,160
+76,159
+80% +$6.74M
IRM icon
205
Iron Mountain
IRM
$36.9B
$16.5M 0.11%
235,618
+107,099
+83% +$6.72M
EPR icon
206
EPR Properties
EPR
$4.69B
$16.5M 0.11%
339,679
+4,882
+1% +$218K
TOST icon
207
Toast
TOST
$19B
$16.4M 0.11%
898,178
+72,483
+9% +$1.19M
GS icon
208
Goldman Sachs
GS
$303B
$16.4M 0.11%
42,513
+27,468
+183% +$9.17M
RARE icon
209
Ultragenyx Pharmaceutical
RARE
$2.46B
$16.4M 0.11%
+342,812
New +$13.3M
CCI icon
210
Crown Castle
CCI
$33.5B
$16.3M 0.11%
141,666
+137,431
+3,245% +$14.1M
IVT icon
211
InvenTrust Properties
IVT
$2.72B
$16.3M 0.11%
643,415
-7,387
-1% -$184K
QGEN icon
212
Qiagen
QGEN
$8.73B
$16.3M 0.11%
353,269
+328,844
+1,346% +$14M
NVT icon
213
nVent Electric
NVT
$25.8B
$16.2M 0.11%
274,665
-208,121
-43% -$11M
GPN icon
214
Global Payments
GPN
$23.6B
$16.1M 0.11%
127,149
-71,265
-36% -$8.25M
OSK icon
215
Oshkosh
OSK
$9.16B
$16M 0.11%
147,987
+54,961
+59% +$5.31M
DLTR icon
216
Dollar Tree
DLTR
$24.9B
$16M 0.11%
112,789
-352,391
-76% -$41.7M
USO icon
217
CALL
United States Oil Fund
USO
$1.91B
$16M 0.11%
240,000
-160,000
-40% -$11.6M
NVR icon
218
NVR
NVR
$16.6B
$16M 0.11%
2,283
+714
+46% +$4.4M
AON icon
219
Aon
AON
$75.9B
$15.9M 0.11%
54,531
+16,391
+43% +$5.25M
IONS icon
220
Ionis Pharmaceuticals
IONS
$9.06B
$15.8M 0.11%
313,274
+251,726
+409% +$12.1M
RH icon
221
RH
RH
$3.29B
$15.8M 0.11%
+54,294
New +$14M
BP icon
222
BP
BP
$114B
$15.8M 0.1%
447,002
-214,830
-32% -$7.87M
CRBG icon
223
Corebridge Financial
CRBG
$14B
$15.8M 0.1%
729,593
+703,834
+2,732% +$14.5M
W icon
224
Wayfair
W
$11.8B
$15.7M 0.1%
255,216
-87,191
-25% -$4.56M
ASND icon
225
Ascendis Pharma A/S
ASND
$16B
$15.7M 0.1%
124,901
+86,001
+221% +$8.57M

Similar funds

Schonfeld Strategic Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Schonfeld Strategic Advisors held 2,384 positions worth $15.1B, up 17% from $12.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Schonfeld Strategic Advisors deployed $548M of net new capital in Q4 2023, opening 671 new positions and adding to 477 existing holdings. Its largest new stake was Equifax: 214,316 shares worth $53M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Union Pacific, an estimated $115M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2023 buy was Equifax: 214,316 shares worth $53M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.67B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2023 reduction was Union Pacific, cutting an estimated $115M.
  • Schonfeld Strategic Advisors fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2023, selling an estimated $94.5M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 29% of its $15.1B portfolio in Q4 2023.
  • Schonfeld Strategic Advisors opened 671 new positions and closed 562 in Q4 2023.
  • Schonfeld Strategic Advisors's portfolio value rose 17% quarter-over-quarter to $15.1B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.